David Mutryn Acquires 1,000 Shares of Maximus (NYSE:MMS) Stock

Maximus, Inc. (NYSE:MMS) CFO David Mutryn acquired 1,000 shares of Maximus stock in a transaction on Monday, February 9th. The shares were bought at an average price of $75.62 per share, with a total value of $75,620.00. Following the purchase, the chief financial officer directly owned 40,037 shares in the company, valued at approximately $3,027,597.94. The trade was a 2.56% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.

Maximus Stock Performance

Maximus stock traded up $0.01 during mid-day trading on Monday, hitting $75.09. The company had a trading volume of 1,168,871 shares, compared to its average volume of 674,064. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88. The company’s fifty day moving average is $90.07 and its 200-day moving average is $86.58. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $100.00. The company has a market capitalization of $4.10 billion, a price-to-earnings ratio of 11.43 and a beta of 0.56.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.01. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company’s revenue for the quarter was down 4.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.61 EPS. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. Equities research analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 13th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 1.8%. The ex-dividend date is Friday, February 13th. This is a positive change from Maximus’s previous quarterly dividend of $0.30. Maximus’s payout ratio is presently 18.26%.

Analyst Ratings Changes

MMS has been the topic of a number of research reports. Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a report on Saturday. Weiss Ratings reiterated a “buy (b-)” rating on shares of Maximus in a research report on Monday, December 29th. Finally, Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. One research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Strong Buy”.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP boosted its position in shares of Maximus by 2.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock worth $170,812,000 after purchasing an additional 36,989 shares during the period. Geode Capital Management LLC grew its stake in shares of Maximus by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider’s stock valued at $127,952,000 after buying an additional 5,130 shares in the last quarter. Boston Partners raised its holdings in shares of Maximus by 47.0% in the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock valued at $88,236,000 after buying an additional 308,892 shares during the period. Reinhart Partners LLC. grew its position in Maximus by 0.8% in the 3rd quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider’s stock valued at $84,206,000 after acquiring an additional 7,722 shares in the last quarter. Finally, Stephens Investment Management Group LLC boosted its stake in shares of Maximus by 49.0% in the third quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock valued at $65,873,000 after purchasing an additional 237,097 shares during the period. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.